|
|
Volumn 7, Issue 12, 2001, Pages 1282-1284
|
|
A new feature on the cholesterol-lowering landscape
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CERIVASTATIN;
CHOLESTEROL;
FATTY ACID;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
LOW DENSITY LIPOPROTEIN RECEPTOR;
STEROL REGULATORY ELEMENT BINDING PROTEIN 1;
STEROL REGULATORY ELEMENT BINDING PROTEIN 2;
STEROL RESPONSE ELEMENT;
UNCLASSIFIED DRUG;
VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;
ANIMAL MODEL;
ATHEROSCLEROSIS;
CHOLESTEROL METABOLISM;
DRUG SAFETY;
DRUG TOLERABILITY;
FATTY ACID SYNTHESIS;
HAMSTER;
HUMAN;
ISCHEMIC HEART DISEASE;
MOLECULAR RECOGNITION;
MUSCULOSKELETAL DISEASE;
PRIORITY JOURNAL;
PROMOTER REGION;
PROTEIN EXPRESSION;
PROTEIN INTERACTION;
RHABDOMYOLYSIS;
RISK FACTOR;
SHORT SURVEY;
STEROL METABOLISM;
ANIMALS;
ANTICHOLESTEREMIC AGENTS;
ANTILIPEMIC AGENTS;
CCAAT-ENHANCER-BINDING PROTEINS;
CHOLESTEROL, LDL;
CRICETINAE;
DNA-BINDING PROTEINS;
INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS;
MEMBRANE PROTEINS;
MODELS, BIOLOGICAL;
RECEPTORS, LDL;
STEROL REGULATORY ELEMENT BINDING PROTEIN 1;
TRANSCRIPTION FACTORS;
UP-REGULATION;
ANIMALIA;
CRICETINAE;
|
|
EID: 0035667676
PISSN: 10788956
EISSN: None
Source Type: Journal
DOI: 10.1038/nm1201-1282 Document Type: Short Survey |
|
Times cited : (34)
|
|
References (11)
|
